Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis.
Despite the availability of multiple disease-modifying therapies for relapsing multiple sclerosis (MS), there remains a need for highly efficacious targeted therapy with a favorable benefit-risk profile and attributes that encourage a high level of treatment adherence. Daclizumab is a humanized monoclonal antibody directed against CD25, the α subunit of the high-affinity interleukin 2 (IL-2) receptor, that reversibly modulates IL-2 signaling. Daclizumab treatment leads to antagonism of proinflammatory, activated T lymphocyte function and expansion of immunoregulatory CD56(bright) natural killer cells, and has the potential to, at least in part, rectify the imbalance between immune tolerance and autoimmunity in relapsing MS. The clinical pharmacology, efficacy, and safety of subcutaneous daclizumab have been evaluated extensively in a large clinical study program. In pivotal studies, daclizumab demonstrated superior efficacy in reducing clinical and radiologic measures of MS disease activity compared with placebo or intramuscular interferon beta-1a, a standard-of-care therapy for relapsing MS. The risk of hepatic disorders, cutaneous events, and infections was modestly increased. The monthly subcutaneous self-injection dosing regimen of daclizumab may be advantageous in maintaining patient adherence to treatment, which is important for optimal outcomes with MS disease-modifying therapy. Daclizumab has been approved in the US and in the European Union and represents an effective new treatment option for patients with relapsing forms of MS, and is currently under review by other regulatory agencies.
Providence Multiple Sclerosis Center; Providence Brain and Spine Institute; Providence Health & Services, Portland, OR, USA.
Stanley
S
Cohan
daclizumab; disease-modifying therapy; humanized monoclonal antibody; relapsing multiple sclerosis; therapeutic use
Science. 2003 Feb 14;299(5609):1057-61
12522256
Lancet Neurol. 2014 May;13(5):472-81
24656609
Mult Scler. 2012 Jul;18(7):932-46
22249762
Nat Genet. 2009 Sep;41(9):1011-5
19701192
Int Immunol. 1998 Dec;10(12):1969-80
9885918
Curr Med Res Opin. 2009 Oct;25(10):2459-70
19678753
N Engl J Med. 1988 Oct 13;319(15):1019-20
3138540
Sci Transl Med. 2012 Aug 1;4(145):145ra106
22855463
Eur J Neurol. 2011 Jan;18(1):69-77
20561039
Clin Pharmacokinet. 2014 Oct;53(10):907-18
25212703
N Engl J Med. 2015 Oct 8;373(15):1418-28
26444729
N Engl J Med. 2012 Sep 20;367(12):1098-107
22992073
Lancet. 2012 Nov 24;380(9856):1819-28
23122652
Annu Rev Immunol. 2008;26:453-79
18062768
Neurology. 1993 Apr;43(4):655-61
8469318
Lancet Neurol. 2009 Mar;8(3):254-60
19201654
N Engl J Med. 2006 Mar 2;354(9):911-23
16510745
Eur J Neurol. 2013 Jan;20(1):79-86
22742892
Nat Rev Immunol. 2013 Feb;13(2):145-9
23348417
J Immunol. 1997 Jan 15;158(2):649-57
8992980
Osteoporos Int. 2010 Jan;21(1):145-55
19459025
Eur J Immunol. 2004 Sep;34(9):2480-8
15307180
Ann Neurol. 2005 Dec;58(6):840-6
16283615
JAMA Neurol. 2015 Jan;72(1):31-9
25419615
Cell Res. 2010 Dec;20(12):1361-71
20820193
Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):241-3
16552790
Brain. 2002 Aug;125(Pt 8):1676-95
12135961
Mult Scler Relat Disord. 2015 Nov;4(6):546-54
26590661
J Immunol. 2010 Jul 15;185(2):1311-20
20543101
Brain. 2007 Apr;130(Pt 4):1089-104
17438020
Mult Scler. 2014 Nov;20(13):1753-60
24740371
Curr Med Res Opin. 2014 Feb;30(2):251-62
24131282
N Engl J Med. 2015 Apr 9;372(15):1476-8
25853765
Brain Pathol. 2004 Apr;14(2):164-74
15193029
Lancet. 2008 Oct 25;372(9648):1502-17
18970977
Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8705-8
15161974
Arch Neurol. 2009 Apr;66(4):483-9
19364933
Immunity. 2014 Sep 18;41(3):354-365
25238093
J Immunol. 2015 Jan 1;194(1):84-92
25416807
J Immunol. 2007 Jan 1;178(1):242-52
17182561
Curr Neurol Neurosci Rep. 2011 Oct;11(5):492-7
21789537
Drugs. 2014 Apr;74(6):659-74
24740824
Nat Immunol. 2003 Apr;4(4):330-6
12612578
N Engl J Med. 2010 Feb 4;362(5):402-15
20089954
Lancet Neurol. 2014 Mar;13(3):247-56
24461574
Lancet. 2013 Jun 22;381(9884):2167-75
23562009
J Neuroimmunol. 2001 Jan 1;112(1-2):153-62
11108944
J Immunol. 2007 Jan 1;178(1):280-90
17182565
Immunity. 2002 Aug;17(2):167-78
12196288
Curr Opin Neurol. 2012 Feb;25 Suppl:S4-10
22398662
J Neuroimmunol. 2016 May 15;294:41-5
27138097
Nat Med. 2011 May;17(5):604-9
21532597
Neurology. 2003 Aug 26;61(4):551-4
12939437
Mult Scler. 2015 Jan;21(1):22-34
25344374
Mult Scler. 2016 Aug;22(9):1215-23
26514979
Ann Med. 2001 Jul;33(5):337-43
11491192
Mult Scler. 1999 Aug;5(4):244-50
10467383
Lancet Neurol. 2014 Jun;13(6):545-56
24685276
J Exp Med. 2005 Mar 7;201(5):723-35
15753206
J Neuroimmunol. 2005 Jun;163(1-2):24-30
15885305
Lancet Neurol. 2010 Apr;9(4):381-90
20163990
J Exp Med. 1985 Jun 1;161(6):1575-80
3925066
Ann Clin Transl Neurol. 2015 May;2(5):445-55
26000318
J Immunol. 2009 Feb 1;182(3):1541-7
19155502
J Manag Care Pharm. 2013 Jan-Feb;19(1 Suppl A):S24-40
23383731
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4230-4
2987968
Brain. 2001 May;124(Pt 5):962-73
11335698
Ann Neurol. 2004 Dec;56(6):864-7
15499632
N Engl J Med. 2006 Mar 2;354(9):899-910
16510744
Hum Mol Genet. 1998 Aug;7(8):1229-34
9668163
Adv Immunol. 1998;70:1-81
9755337
Mult Scler. 2012 Jun;18(2 Suppl):7-15
22623122
J Clin Immunol. 2007 Jan;27(1):1-18
17216565
Neurol Neuroimmunol Neuroinflamm. 2015 Jan 22;2(2):e65
25635261
Science. 1988 May 27;240(4856):1169-76
3131876
BMC Neurol. 2014 Dec 31;14:240
25551571
J Exp Med. 2007 Jan 22;204(1):65-71
17227909
Lancet. 2012 Nov 24;380(9856):1829-39
23122650
Mult Scler. 2011 Dec;17(12):1441-8
21807759
Neurology. 1995 Jul;45(7):1268-76
7617181
Br J Clin Pharmacol. 2016 Jul;82(1):160-7
26991517
Ther Adv Neurol Disord. 2011 Jan;4(1):3-14
21339904
Eur J Hum Genet. 2010 Jul;18(7):794-9
20179739
Transpl Immunol. 2000 Nov;8(3):153-9
11147695
N Engl J Med. 2012 May 17;366(20):1870-80
22591293
Science. 2005 Nov 18;310(5751):1159-63
16293754
Neurology. 2011 Nov 22;77(21):1877-86
22076546
Expert Rev Neurother. 2014 Jun;14(6):607-16
24834466
J Immunol. 1988 Apr 1;140(7):2243-8
3258332
Patient. 2016 Apr;9(2):171-80
26259849
Lancet Neurol. 2009 Jun;8(6):545-59
19446274
J Immunol. 1985 Nov;135(5):3172-7
3930598
Nature. 1992 Mar 5;356(6364):63-6
1538783
Clin Ther. 2015 Oct 1;37(10):2366-80
26365096
Ann Neurol. 1996 Mar;39(3):285-94
8602746
Clin Drug Investig. 2010;30(2):89-100
20067327
BMC Neurol. 2016 Jul 26;16:117
27461166
Lancet. 2011 Nov 19;378(9805):1779-87
22047971
Mult Scler. 2014 Apr;20(4):464-70
24022270
J Neurol Sci. 2007 May 15;256 Suppl 1:S14-8
17337274
J Immunol. 2002 Nov 1;169(9):4850-60
12391195
Neurology. 2007 Aug 21;69(8):785-9
17709711
N Engl J Med. 2007 Aug 30;357(9):851-62
17660530
Arch Neurol. 2009 Apr;66(4):471-9
19364932
N Engl J Med. 2011 Oct 6;365(14):1293-303
21991951
Expert Opin Pharmacother. 2006 Oct;7 Suppl 1:S1-9
17020427
Mult Scler. 2008 May;14(4):479-84
18562504
J Immunol. 2011 Jul 15;187(2):781-90
21666061
Mult Scler. 2014 Feb;20(2):156-64
23846354
Clin Pharmacol. 2016 Feb 11;8:9-13
26929672
J Neurol. 2014 Feb;261(2):316-23
24375015
Mult Scler Int. 2014;2014:285245
25374694
J Immunol. 1995 Aug 1;155(3):1151-64
7636184
Hepatology. 2010 Jun;51(6):2117-26
20512999
Mult Scler. 2000 Aug;6(4):267-73
10962547
Immunol Today. 1993 Jun;14(6):264-70
8397768
Int Immunol. 2008 Mar;20(3):421-31
18270368
Adv Ther. 2011 Jan;28(1):51-61
21153000
Clin Rehabil. 2006 Jan;20(1):67-78
16502752
Clin Pharmacokinet. 2016 Jan;55(1):121-30
26242380
Nature. 1994 May 26;369(6478):333-6
7514277
J Immunol. 2001 Aug 1;167(3):1245-53
11466340
N Engl J Med. 2012 Sep 20;367(12):1087-97
22992072
N Engl J Med. 2010 Feb 4;362(5):387-401
20089952
Nat Immunol. 2005 Nov;6(11):1142-51
16227984
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5941-6
16585503
Lancet. 1998 Nov 7;352(9139):1498-504
9820297
Patient. 2014 Jul 12;:
25015302
Eur J Neurol. 2009 Nov;16(11):1202-9
19538207
Clin Ther. 2003 Aug;25(8):2307-35; discussion 2306
14512137
Curr Neurol Neurosci Rep. 2012 Oct;12(5):489-91
22760478
Ann Neurol. 2013 Mar;73(3):327-40
23424159
Trends Neurosci. 2010 Mar;33(3):140-52
20045200
Nat Rev Neurol. 2013 Jul;9(7):394-404
23732529